Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 21, 2009; 15(27): 3367-3375
Published online Jul 21, 2009. doi: 10.3748/wjg.15.3367
Published online Jul 21, 2009. doi: 10.3748/wjg.15.3367
Table 4 MRI category, medical therapy and clinical response (%)
| MRI group | Steroids | 5ASA | Antibiotics | AZA/6MP | MTX | Anti-TNF α | Response |
| 1 (n = 7) | 57.10 | 57.10 | 28.50 | 85.70 | 0.00 | 42.90 | 14.30 |
| 2 (n = 9) | 55.50 | 88.90 | 0.00 | 22.20 | 33.30 | 44.40 | 100.00 |
| 3 (n = 16) | 81.30 | 68.80 | 6.30 | 50.00 | 0.00 | 12.50 | 43.80 |
| 4 (n = 20) | 70.00 | 70.00 | 5.00 | 40.00 | 0.00 | 35.00 | 50.00 |
| Responders (n = 27) | 63.00 | 63.00 | 11.10 | 44.40 | 3.70 | 25.90 | N/A |
| Non-responders (n = 25) | 76.00 | 80.00 | 4.00 | 48.00 | 8.00 | 36.00 | N/A |
- Citation: Lawrance IC, Welman CJ, Shipman P, Murray K. Correlation of MRI-determined small bowel Crohn’s disease categories with medical response and surgical pathology. World J Gastroenterol 2009; 15(27): 3367-3375
- URL: https://www.wjgnet.com/1007-9327/full/v15/i27/3367.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3367